Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MRCOG part 2 > Antepartum Care > Flashcards

Antepartum Care Flashcards

1
Q

Incidence of placenta praevia

A

1 in 200 pregnancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Resolution rate of placenta praevia at 32 weeks

A

90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Resolution rate of placenta praevia at 36 weeks

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cervical length of less than ________ predicts antepartum haemorrhage and emergency c/s

A

31mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors for placenta praevia

A

Smoking
ART
Caesarean birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Timing of steroids for placenta praevia

A

34+0 to 35+6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Timing of delivery in placenta praevia

A

34+0 - 36+6 if vaginal bleeding/other risk factors

36+0 - 37+0 if uncomplicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Risk of bleeding by gestation with placenta praevia

A

4.7% by 35 weeks
15% by 36 weeks
30% by 37 weeks
59% by 38 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Risk of MOH requiring blood transfusion with placenta praevia c/s

A

12 x higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk factors for PAS

A

C/S
Previous uterine surgery
Placenta praevia
IVF
Maternal age
Bicornuate uterus
Adenomyosis
Submucous fibroids
Myotonic dystrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Rate of PAS with praevia and 3 or more c/s

A

50-67%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Proportion of PAS undiagnosed

A

1/3 to 2/3rds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

USS signs of PAS

A

Abnormal uterus-bladder interface
Abnormal vasculature on colour Doppler
Abnormal Placental lacunae vascularity
Increased vascularity of the placental bed
Loss of clear zone
Myometrial thinning
Placental bulge
Focal exophytic mass
Bridging vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MRI signs of PAS

A

Abnormal uterine bulging
Dark intraplacental bands
Heterogenous signal intensity in placenta
Disorganised vasculature of placenta
Disruption of uteroplacental zone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gestation for delivery with PAS

A

35+0 to 36+0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk of urinary tract injury during PAS surgery

A

16% of uterus preserved
57% with standard hysterectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Risks of conservative management of PAS (placenta in situ)

A

Infection
Bleeding
Septic shock
Peritonitis
Uterine necrosis
Fistula
Pulmonary oedema
Acute renal failure
VTE
Injury to adjacent organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Emergency cerclage can be considered up from ______ to _____ gestation

A

16+0 to 27+6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Risk of preterm birth with cervical length of <25mm and history of PTB

A

14%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Indications for serial cervical length scans

A

Previous PTB/2nd trimester loss 16-34 weeks
Previous PPROM <34 weeks
Previous cerclage
Intrauterine adhesions
Known uterine variant
History of trachelectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Indication for trans abdominal cerclage

A

Previous failed vaginal cerclage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Risks of cervical cerclage

A

Cervical laceration
Bladder injury
Membrane rupture
Fistula formation
Removal under anaesthetic required if performed with bladder mobilisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Removal of cervical suture should be at

A

36+1 to 37+0 unless pt undergoing c/s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

History indicated cerclage

A

Singleton, 3 or more preterm births
Singleton, history of second trimester loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Gestation at which you MUST remove cervical cerclage after PPROM

A

Less than 23 weeks
More than 34 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Incidence of PPROM

A

3%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

PPROM occurs in what percentage of PTB

A

30-40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Median latency after PPROM

A

7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Management of PPROM

A

Delivery if septic
Erythromycin (penicillin if allergic) 10 days or established labour
Offer steroids between 24+0 to 33+6
Consider steroids 34+0 to 35+6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Benefit of abx in PPROM

A

Reduce babies born within 48 hours and within 7 days
Reduce risk of chorio
Reduces risk of neonatal infection, surfactant use, oxygen therapy and abnormal cerebral USS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Most helpful marker of chorioamnionitis

A

CRP (77% specificity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Tocolysis in PPROM is not recommended because

A

Associated with lower APGAR scores (<7) and increased need for ventilatory support
Increased risk of chorio below 34 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Timing of Delivery following PPROM

A

37+0

From 34+0 if GBS pos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

MgSO4 for PPROM

A

Offer when Planned or established labour 24+0 to 29+6
Consider between 30+0 and 33+6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Average time to delivery after PPROM

A

8-10 days at 24+0 to 28+0
5 days at 31+0

May be sooner if there is oligo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Factors leading to worse outcomes for PPROM

A

Oligo
Non-cephalic presentation
Occurring <26+0

Consider hospital care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Benefits of antenatal steroids

A

Reduce NND
Reduce NEC
Reduce RDS
Reduce intraventricular haemorrhage
Reduce risk of infection in first 48 hours of life
Reduces risk of ITU admission/respiratory support
Reduce developmental delay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Optimal Timing of steroids

A

Greatest benefit with delivery within 48 hours of first dose

Benefit seen within 24 hours of delivery
Benefit for up to 7 days of giving

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Dose and type of steroids

A

Dexamethasone phosphate 12mg 24 hours apart or 4 doses of 6mg given 12 hourly (better risk reduction for IVH)

Betamethasone phosphate/acetate mix - 12mg 24 hours apart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Gestations to give steroids

A

Offer between 24+0 to 34+6

Consider 35+0 to 36+6

Consider between 22+0 to 23+6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Harms of steroids

A

Affects maternal glycaemic control for 5 days
Neonatal hypoglycaemia
Reduced birth weight with repeat courses
Neurodevelopmental affects if baby born at term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Stillbirth rate

A

32 in 10, 000 (white)
72 in 10, 000 (black)
51 in 10, 000 (Asian)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Consider Prophylactic vaginal progesterone when

A

History of PTB up to 34+0/2nd trimester loss OR cervical length is <25mm on TV USS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Offer either cerclage or vaginal progesterone when

A

History of PTB/2nd trimester loss AND cervical length <25mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Gestation to give vaginal progesterone

A

Start between 16+0 and 24+0
Continue until 34+0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Offer prophylactic cerclage when

A

History of cervical trauma OR
History of PPROM

AND cervical length <25mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Contraindications for emergency cerclage

A

Uterine contractions
Active vaginal bleeding
Signs of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Diagnosis of PTB at 30+0 or more

A

15mm cervical length on TV USS (preferred)
OR
Fetal fibronectin >50

Treat for PTB if above tests not available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Tocolysis should be given at what gestation?

A

Consider between 24+0 and 26+0
Offer PTB between 26+0 and 33+6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Tocolysis medication

A

Nifedipine
Oxytocin receptor antagonists if nifedipine is contraindicated (atosiban)

Do not use betamimetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Monitoring of FH in established PTB

A

Offer IA or CTG if no other risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Fetal scalp electrode monitoring should not be used below _____ gestation

A

34+0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

FBS should not be used below ______ gestation

A

34+0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Cord clamping technique in preterm babies

A

60 seconds
Hold baby below the level of the placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Incidence of PTB

A

7.3% of live births

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Gestation for amniocentesis

A

15+0

Higher risk of low DNA quantity prior to 16+0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Risks of amniocentesis

A

Miscarriage 0.5%
Second sample required 6%
Blood stained sample 0.8%
Maternal cell contamination 1-2%
Rapid test failure 2%
Failed cell culture 0.5-1%
Severe infection
Fetal injury
Maternal visceral injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Risks of CVS

A

Miscarriage 0.5%
Second sample required 6%
Confined placental mosaicism 2%
Failed cell culture 0.5-1%
Severe infection
Fetal injury
Maternal visceral injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Gestation for CVS

A

10+0 minimum
Ideally after 11+0 to reduce technical difficulty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Pregnancy loss risk for CVS/amniocentesis in multiple pregnancy

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Risk of cross contamination in multiple pregnancy CVS

A

1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Risks of 3rd trimester amniocentesis

A

10% risk cell culture failure
PTB 3-4%
More than one needle insertion 5%
Blood stained sample 5-10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Amniocentesis/CVS considerations with blood borne viruses

A

Testing required prior to test
Ensure HIB viral load is undetectable
Ensure Hep B viral load is <6.99log10 copies/ml
No evidence for Hep C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Maternal mortality rates

A

11.66 per 100, 000 (white)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Definition of early FGR

A

Onset before 32+0
Fetal size or AC <3rd centile OR absent EDF

OR

<10th centile with uterine artery >95th or UA PI >95th centile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Static growth definition

A

No forward growth velocity in AC or EFW measured 14 days apart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Definition of late FGR

A

> 32+0
AC/EFW <3rd centile

OR (2 of the following):

AC/EFW <10th centile
AC/EFW crossing 2 quartiles
Cerebroplacental ratio <5th centile or UA PI >95th centile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Definition of FGR in previous pregnancy

A

Previous baby <3rd centile
PET or FGR requiring birth <34+0
EFW <10th centile with evidence of placental dysfunction

69
Q

Optimal time to start aspirin

A

11+0 to 16+6

70
Q

Incidence of early onset FGR

71
Q

Timing of SFH measurement

A

First measurement between 26+0 and 28+6
No more than every 2 weeks, at each appointment

72
Q

Method to determine EFW

A

Haddlock formula

73
Q

Gestation for uterine artery Doppler

A

20+0 - 24+6

74
Q

Fetal infection accounts for what percentage of SGA?

75
Q

Short femur length is associated with _____________

A

SGA and PTB

76
Q

Early FGR coincides with maternal hypertension in ________ of cases

77
Q

Treatment for anaphylaxis

A

1:1000 adrenaline 500mcg IM (0.5ml)

78
Q

Incidence of cardiac arrest in pregnancy

A

1 in 36000 pregnancies

79
Q

Mortality rate of cardiac arrest

80
Q

Commonest cause of cardiac arrest in pregnancy

A

Anaesthetic (25%)

81
Q

Commonest cause of maternal collapse

A

Vasovagal syncope
Epileptic seizures

82
Q

MOH incidence

83
Q

Incidence of AFE

A

1.7 per 100, 000

84
Q

Mortality rate with AFE

A

67 per 1000

85
Q

Incidence of severe perioperative obstetric anaphylaxis

A

1-3.5 per 100, 000

86
Q

Mortality rate from perioperative obstetric anaphylaxis

87
Q

Tryptase levels following anaphylaxis

A

After resuscitation has started
1-2 hours later
24 hours later

88
Q

Aortocaval compression in pregnancy reduces CPR cardiac output by _____

A

From 30% to 10%

89
Q

How to minimise aspiration pneumonitis risk? (Mendelsson syndrome)

A

Early intubation
Cricoid pressure
H1 anatagonists
Antacids

90
Q

Left lateral tilt angle

A

15-30 degrees

91
Q

Percentage cardiac output to placenta at term

92
Q

Aortacaval compression impairs venous return by ______

93
Q

Perimortem c/s should be done at ____ gestation and within ___ minutes of cardiac arrest

A

20+0
5 minutes

94
Q

Fluid replacement in sepsis

A

30ml/kg within 3 hours

95
Q

Target MAP in hypovolaemia

96
Q

Intralipid infusion protocol

A

Bolus 15ml/kg over 1 minute then 15ml/kg/hr
Further bolus at 5 minute intervals if no return of circulation
Increase infusion to 30ml/kg/hr if needed

97
Q

Maximum dose of intralipid

98
Q

Anaphylaxis treatment

A

1:1000 adrenaline 0.5ml IM
Repeat after 5 minutes
50 microgram IV bolus can be given by experienced Dr

99
Q

Incidence of maternal cardiac arrest

A

2.78 per 100 000

100
Q

Fetal survival after perimortem C/S

101
Q

Vasa praevia type 1 definition

A

Vessel connects to velamentous umbilical cord

102
Q

Vasa praevia type 2 definition

A

Vessels connect placenta with succenturiate lobe

103
Q

Vasa praevia prevalence

A

1 in 1200 to 1 in 5000

1 in 250 with IVF

104
Q

Survival rates of vasa praevia when diagnosed antenatally with planned delivery

105
Q

Risk factors for vasa praevia

A

Velamentous cord insertion
Placenta praevia
Bilobed placenta
Succenturiate placental lobes
ART

106
Q

What percentage of cases of vasa praevia resolve

107
Q

Rate of spontaneous version from breech to cephalic at term (primip)

108
Q

Rate of reversion to breech after ECV

109
Q

Factors associated with ECV success

A

Non-Engagement of breech
Palpable fetal head
Maternal weight <65kg
AFI >10
Tocolysis
Multiparous

110
Q

Reason for c/s in labour after successful ECV

A

Slow progress
Fetal distress

111
Q

When to perform ECV

A

37+0
Primips could have from 36 weeks

112
Q

Rate of emergency c/s after ECV

A

1 in 200 within 24 hours

113
Q

Indications for emergency c/s after failed ECV

A

Vaginal bleeding
Abnormal FH

114
Q

Recurrence rate of breech presentation

115
Q

APH definitions

A

Spotting
Minor - <50ml and settled
Major - 50-1000ml with no sign of shock
Massive - >1000ml or sign of shock

116
Q

Abruption incidence

A

Overall 0.5-1%
4.4% after 1
25% after 2

117
Q

Severe abruption definition

A

Presence of:
(Maternal) shock, DIC, RBC requirement, hysterectomy, renal failure, death

(Fetal) IUD/NND, non-reassuring status, PTB, SGA

118
Q

Risk factors for abruption

A

Previous
PET/essential HTN
FGR
PPROM
Old age
Multiparity
Smoking
Cocaine
Intrauterine infection
First trimester bleeding
Low BMI
ART
Abdominal trauma
Multiple pregnancy
Thrombophilia
Folic acid deficiency

119
Q

Complications of abruption

A

Infection
Anaemia
Shock
DIC
AKI
Couvelere uterus
PPH
Ischaemia of distal organs (adrenal glands/pituitary)
Feto-maternal haemorrhage
Psychological sequalae

120
Q

Risk of hysterectomy with placenta praevia + previous c/s

121
Q

Extra peri-operative considerations for PAS

A

Ureteric stents
Iliac artery balloon insertion, fill after delivery for haemostasis

122
Q

Risk of recurrence of uterine rupture

123
Q

Risk factors for uterine rupture

A

Previous c/s
Previous uterine surgery
Previous rupture
High parity
Induction/augmentation
Hyper stimulation
Mal presentation
Macrosomia
Uterine anomaly
Trauma

124
Q

Uterine rupture causes CTG abnormalities in what percentage of cases

125
Q

Uterine rupture maternal mortality

A

17 per 100 000

126
Q

Stage 1 DIC

A

Hypercoagulable state
Activation of clotting factors and development of microthrombi
Decreased clotting and increased platelet aggregation

127
Q

Stage 2 DIC

A

Consumptive coagulants state
Increased consumption of platelets and clotting factors
Bleeding
Increased clotting
Decreased platelets
Decreased fibrinogen

128
Q

Stage 3 DIC

A

Secondary fibrinolytic state
Formation of fibrin degradation products and plasmin
Marked bleeding
Increased thrombin time, decreased clot lysis time, increased fibrin degradation products

129
Q

Prophylaxis of PPH

A

Correct DIC
Ensure euvolaemia with CVP 5-10mmHg
Synt
Rub up uterus
Keep patient warm
Re-assess DIC status

130
Q

Iron requirement in pregnancy

A

2.5mg/day first trimester
6.66mg/day third trimester

131
Q

Iron deficiency ferritin level

132
Q

B12 deficiency complications

A

PTB
Low birth weight

133
Q

Maternal Complications of iron deficiency anaemia

A

PPH
Sepsis
PPD
Fatigue
Maternal death globally

134
Q

Fetal complications of iron deficiency

A

Perinatal and neonatal mortality
SGA
PTB
Neurodevelopmental impairment

135
Q

Oral iron replacement regime

A

Recheck Hb 2-3 weeks
Continue for 3 months or 6 weeks post partum

136
Q

High dose folic acid for which women?

A

BMI >30
Taking AEDs
Previous affected pregnancy
Family history
T2DM and T1DM
Sickle cell disease
Thalassaemia

137
Q

How is HbA2 measured

A

With HPLC test

138
Q

HbA2 is _______ in sickle cell/thalassaemia carriers

139
Q

Complications of thalassaemia

A

Hypersplenism
Delayed puberty
Hormone problems
Cardiomyopathy
Hepatitis, fibrosis, cirrhosis
Joint pains and osteoporosis

140
Q

Chromosome deletion in alpha thalassaemia

141
Q

Alpha thalassaemia trait

A

2 abnormal alleles
Mild anaemia - hypochromic microcytic

142
Q

Haemoglobin H disease

A

Unstable haemoglobins
Tetrameric gamma chains (Bart’s)
Tetrameric beta chains (H)

143
Q

Blood film features of haemoglobin H disease

A

Microcytic hypochromic anaemia
Target cells
Heinz bodies (precipitated HbH)

144
Q

Risk of cord prolapse with breech

A

1% footling breech (10% breech babies)

145
Q

Contraindications to VBAC

A

Previous uterine rupture
Classical incision
Other absolute contraindications

146
Q

Incidence of OASI after SVD

A

3.6% overall
Pri 5.4%
Multip 1.6%

147
Q

Incidence of OASI after instrumental delivery

A

Pri 7.8%
Multip 4.8%

148
Q

Repair of anorectal mucosa technique and suture

A

Continuous or interrupted
3-0 polyglactin

149
Q

IAS repair technique and sutures

A

Repair separately from anorectal mucosa and EAS
Interrupted or mattress sutures, do not overlap
Use 3-0 PDS or 2-0 polyglactin

150
Q

EAS repair technique and suture material

A

End to end for 3a and 3b
Can use overlapping for full thickness EAS tear
Use 3-0 PDS or 2-0 polyglactin

151
Q

Prognosis of OASI

A

60-80% asymptomatic at 12 months

152
Q

Mode of delivery after OASI

A

C/S if has symptoms after 1 year or abnormal endoanal ultrasound

153
Q

Sub-occipito bregmatic diameter is

A

9.5cm
Flexed OA

154
Q

Suboccipito-frontal diameter is

A

10cm
Incompletely flexed OA

155
Q

Occipito-frontal diameter is

A

11.5cm
OP position

156
Q

Submento-bregmatic diameter is

A

9.5cm
face presentation with head completely deflexed

157
Q

Submento-vertical diameter is

A

11.5cm
Face presentation incompletely extended

158
Q

Mento-vertical diameter is

A

13.5cm
Brow presentation
Cannot deliver vaginally

159
Q

Risk of SGA with low PAPP-A

160
Q

BM targets in women with pre-existing diabetes

A

Fasting <5.3
1 hr Post prandial <7.8
2 hr post meal <6.4
Timing range >70% if using continuous monitoring

161
Q

Best method to measure BM for pre-existing type 1 DM

A

Continuous glucose monitoring - reduces LGA, NNU admission and hypoglycaemia

Consider for type 2 when not meeting targets

162
Q

Retinopathy screening timing

A

At booking
At 16-20 weeks of disease
28 weeks

No restrictions on treatment in pregnancy

163
Q

Risk of type 2 diabetes after GDM

A

50% in 5 years

164
Q

Offer insulin for GDM at diagnosis when

A

Fasting glucose >7
OR
Fasting 6-6.9 with fetal macrosomia or polyhydramnios

165
Q

Start merformin/insulin for GDM after trial of diet when ____

A

Fasting BM > 5.3
BM >7.8 post meal

166
Q

GDM timing of birth

A

Offer T+5 if uncomplicated
Deliver no later than T+6

167
Q

HbA1c measurement for pre-existing DM

A

At booking and each trimester

168
Q

Recommended delivery mode and timing after uterine transplant

A

37/40
Caesarean delivery

MRCOG part 2 (22 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions